ARCHIVES

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Panel Urges New Research Consortium For Stomach, Esophageal Cancers

January 17, 2003

NCI Intramural Budget And List Of Highest-Funded Branches, Laboratories

April 21, 1995

New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials

December 28, 2001

Sales of Smoking Cessation Aids Increase, Effectiveness Drops

October 25, 2002

NCI Sends Letter To Grantees To Explain Tighter Funding.

March 16, 2001

Congressional committee investigates former NCI Director Richard Klausner’s role in $40 million Harvard contract; NIH begins internal review. Klausner: investigation casts “strange innuendoes.” Text of committee’s letter.

November 14, 2003